These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7740443

  • 1. A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.
    Cohen AT, Phillips MJ, Edmondson RA, Skinner JA, Das SK, Cooper DJ, Thomas EM, Melissari E, Kakkar VV.
    Thromb Haemost; 1994 Dec; 72(6):793-8. PubMed ID: 7740443
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group.
    Di Carlo V, Agnelli G, Prandoni P, Coccheri S, Gensini GF, Gianese F, Mannucci PM.
    Thromb Haemost; 1999 Jul; 82(1):30-4. PubMed ID: 10456450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy.
    Imbimbo BP, Sié P, Agnelli G, Saivin S, Dupouy D, Damiani M, Houin G, Gianese F.
    Thromb Haemost; 1994 May; 71(5):553-7. PubMed ID: 8091379
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
    Adolf J, Fritsche HM, Haas S, Hennig FF, Horbach T, Kastl S, Koppenhagen K, Michaelis HC, Rhamanzadeh R, Summa W, Wagner W, Weber U, Wolf H.
    Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
    [Abstract] [Full Text] [Related]

  • 7. [Prevention of deep vein thrombosis by enoxaparin after total hip prosthesis].
    Vochelle N, Planes A.
    Agressologie; 1990 Mar; 31(3):145-8. PubMed ID: 2173435
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Mar; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement.
    Francis CW, Pellegrini VD, Leibert KM, Totterman S, Azodo MV, Harris CM, Cox C, Marder VJ.
    Thromb Haemost; 1996 May; 75(5):706-11. PubMed ID: 8725709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. A pilot study.
    Trowbridge A, Boese CK, Woodruff B, Brindley HH, Lowry WE, Spiro TE.
    Clin Orthop Relat Res; 1994 Feb; (299):203-8. PubMed ID: 8119019
    [Abstract] [Full Text] [Related]

  • 16. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G, Lu H, Gao J, Kou B, Yuan Y, Xu B.
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [Abstract] [Full Text] [Related]

  • 17. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
    Guan ZP, Lü HS, Chen YZ, Song YN, Qin XL, Jiang J.
    Zhonghua Wai Ke Za Zhi; 2005 Oct 15; 43(20):1317-20. PubMed ID: 16271243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V, Vuorinen J, Myllynen P, Kivioja A, Lindevall K.
    Ann Chir Gynaecol; 1996 Oct 15; 85(4):359-63. PubMed ID: 9014067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.